Development of pleural and pericardial effusions during itraconazole therapy of pulmonary aspergillosis

  • J. Günther
  • H. Lode
  • M. Raffenberg
  • T. Schaberg
Letters

Keywords

Internal Medicine Itraconazole Aspergillosis Pericardial Effusion Itraconazole Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Sharkey PK, Rinaldi MG, Dunn JF, Hardin TC, Fetchick RJ, Graybill JR High-dose itraconazole in the treatment of severe mycoses. Antimicrobial Agents and Chemotherapy 1991, 35: 707–713.PubMedGoogle Scholar
  2. 2.
    Denning DW Itraconazol bei systemischen Pilzinfektionen. Medizinische Klinik 1991, 86, Supplement 1: 3–4.PubMedGoogle Scholar
  3. 3.
    Hostetler JS, Stevens DA Die Behandlung von Aspergillosen, Kryptokokken und Histoplasmosen bei immungeschwächten Patienten. Medizinische Klinik 1991, 86, Supplement 1: 13–19.PubMedGoogle Scholar
  4. 4.
    Bayles MAH Tropische Mykosen. Medizinische Klinik 1991, 86, Supplement 1: 23–25.Google Scholar
  5. 5.
    Viviani MA Mykosen als opportunistische Infektionen bei AIDS-Patienten. Medizinische Klinik 1991, 86, Supplement 1: 19–22.PubMedGoogle Scholar
  6. 6.
    Dismukes WE, Bradsher RW, Cloud GC, Kauffman CA, Chapman SW, George RB, Stevens DA, Girard WM, Saag MS, Bowles-Patton C, andothers in the NIAID Mycoses Study Group Itraconazole therapy for blastomycosis and histoplasmosis. American Journal of Medicine 1992, 93: 489–497.CrossRefPubMedGoogle Scholar
  7. 7.
    Saag MS, Dismukes WE Azole antifungal agents emphasis on new triazoles. Antimicrobial Agents and Chemotherapy 1988, 32: 1–8.PubMedGoogle Scholar
  8. 8.
    Tucker RM, Hag Y, Denning DW, Stevens DA Adverse events associated with itraconazole in 189 patients on chronic therapy. Journal of Antimicrobial Chemotherapy 1990, 26: 561–566.PubMedGoogle Scholar
  9. 9.
    Van Cutsem I In-vitro und in-vivo Aktivität von Itraconazol. Medizinische Klinik 1991, 86, Supplement 1: 5–8.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1993

Authors and Affiliations

  • J. Günther
    • 1
  • H. Lode
    • 1
  • M. Raffenberg
    • 1
  • T. Schaberg
    • 1
  1. 1.Section of Immunology and Infectious Diseases, Department of Pulmonary MedicineZehlendorf HospitalBerlinGermany

Personalised recommendations